DA Davidson reiterates Fifth Third stock Buy rating on synergies

DA Davidson reiterated a Buy rating and $58 price target on Fifth Third Bancorp, implying about 14% upside from the $50.90 share price. The bank closed its Comerica acquisition on February 1, raised the low end of net interest income guidance, and expects ROTCE to reach about 19% by Q4 2026, while maintaining a 3.18% dividend yield. Recent Q1 2026 results also beat EPS expectations at $0.15 versus -$0.10, though revenue slightly missed at $2.83 billion versus $2.85 billion.

Analysis

The market is likely underpricing how quickly a deal-driven earnings step-up can re-rate FITB’s multiple. The key second-order effect is not just higher NII from a more asset-sensitive balance sheet, but a broader operating leverage reset: post-integration revenue synergies plus a structurally better efficiency profile can push ROTCE toward a peer-premium regime, which typically justifies multiple expansion before the full P&L benefit is visible.

CMA is the obvious loser on a standalone basis: the market may continue to handicap residual integration friction, stranded cost absorption, and the loss of strategic optionality. More importantly, every month the combined FITB platform executes cleanly, the comparative argument for other regional banks weakens; peers with similar deposit franchises but no transaction catalyst may see relative multiple compression as investors rotate into names with visible self-help.

The contrarian risk is that the current enthusiasm already reflects a large part of the synergy story, while the next few quarters could be noisy. Integration execution, credit normalization, and deposit beta pressure are the main ways the trade can fail over a 1-2 quarter horizon, and those risks matter more than the headline target because the market is likely to punish any sign that the earnings runway slips beyond 2026.

The more interesting setup is that upside may be better expressed as a relative-value trade than an outright long. If management delivers even incremental evidence of faster synergy capture, FITB can outperform a broader regional basket by several hundred bps over the next 3-6 months, while CMA’s relative underperformance could persist until the market has clearer visibility on the post-deal earnings floor.

Key Decisions for Investors

• Go long FITB vs. short CMA in a 1:1.5 notional pair for the next 3-6 months; thesis is that execution visibility and post-merger operating leverage should drive FITB relative outperformance while CMA remains a dead-money benchmark drag.
• Add FITB on any 3-5% pullback over the next 2-4 weeks; risk/reward favors buying weakness because the next catalyst is likely incremental guidance confidence rather than a fresh headline, and the stock should re-rate before full synergy realization.
• For options, buy FITB call spreads 3-6 months out rather than outright calls; this captures multiple expansion while limiting downside if integration noise causes a post-print compression.
• Avoid chasing CMA long exposure until there is evidence the market is assigning a stable standalone valuation floor; the more likely path is continued relative underperformance versus stronger post-M&A regional banks.